Dose proportionality and BE [Design Issues]

posted by sciguy – Canada, 2011-11-02 17:52 (5345 d 02:52 ago) – Posting: # 7586
Views: 11,225

Hi all,

I'm new to the forum and just wanted to get opinions from the group on the following issue:
The sponsor wants to compare two different formulations of a drug with 2 different strengths, say 5 mg vs 10 mg. Dose normalization on the relevant PK parameters is performed and the assessment of equivalence using standard BE criteria is applied. If BE is met, we can only conclude dose proportionality but not bioequivalence since 2 different strengths are being compared. True bioequivalence must be evaluated on non dose-normalized data. Agree/disagree?

Thanks a lot!

sciguy

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
116 visitors (0 registered, 116 guests [including 11 identified bots]).
Forum time: 21:45 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5